Clinical Trial Matching

Fight CRC Partners with Perthera to Deliver Precision Oncology to Cancer Patients | 7/15/2020

Fight CRC is partnering with Perthera, the market leader in precision oncology to provide precision cancer care answers to patients from across the nation with colon and rectal cancers. This collaborative effort will deliver molecular profiling, personalized treatment recommendations, and clinical trial matching to patients with colorectal cancer. “We are excited to not only work with Fight CRC on this program, with staff and volunteers that have driven many successful …

Quantum Leap Healthcare Collaborative Announces the Selection of Byondis’ SYD985 in the I-SPY 2 TRIAL for Stage 2/3, High-Risk Breast Cancer | PR Newswire | 7/7/2020

… San Francisco and Silicon Valley entrepreneurs. Our mission is to integrate care and research, and to foster high-impact trials with embedded clinical processes and systems technology and improved data management, greater access to clinical trial matching , and greater benefit to patients, providers and researchers. Our goal is to improve and save lives. Quantum Leap provides operational, financial, and regulatory oversight to I-SPY. For more information, visit https://www.quantumleaphealth.org …

Follow Clinical Trial Matching:    

Intermountain Healthcare Implements DeepThink Health’s Precision Intelligence Solutions to Manage its Molecular Tumor Board | PR Newswire | 7/7/2020

… a specific patient to similar patients and analyze their outcome and prognosis within the institution or across broader evidence sharing networks. The solution enables evidence-based decision making for molecular testing, therapy selection, and clinical trial matching . It provides quality and compliance reporting, as well as outcome analytics to monitor consistency in care and value-based performance. “We are excited to partner with DeepThink as we continue to advance our …

MD Anderson and Philips collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers | BioSpace | 6/17/2020

HOUSTON and AMSTERDAM, Netherlands The University of Texas MD Anderson Cancer Center and Royal Philips today announced a collaboration to provide oncologists with evidence-based therapy and clinical trial guidance through Philips’ oncology informatics solutions and MD Anderson’s Precision Oncology Decision Support (PODS) system. This collaboration will allow physicians around the world to personalize therapy based on the patient’s genomic profile, with the aim of improving patient care. MD Anderson …

Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers | Globe Newswire | 6/16/2020

June 16, 2020 09:00 ET Source: Royal Philips Physicians discuss patient treatment options Oncology informatics provides actionable information to physicians June 16, 2020 Philips connects oncologists and pathologists around the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of actionable clinical information Amsterdam, the Netherlands, and Houston, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and The University of Texas MD Anderson Cancer …

Covance launches COVID-19 clinical trial matching platform | 6/10/2020

The drug development firm has introduced COVID-19 Clinical Trial Connect, a site designed to help potential patients match with research studies. Covance, the drug development business of LabCorp, has launched Clinical Trial Connect in the US. The web-based service is designed to help people access information about COVID-19 trials and tell them how they can participate in research. Michael Brooks, president of clinical development and commercialization solutions …

Quantum Leap Healthcare Collaborative Announces the Selection of Sanofi’s SAR439859 as the oral SERD Backbone Agent in the Endocrine Optimization Pilot Study of the I-SPY 2 TRIAL for Clinically High Risk, Molecularly Low Risk Stage 2/3 Breast Cancer | PR Newswire | 6/8/2020

… San Francisco and Silicon Valley entrepreneurs. Our mission is to integrate care and research, and to foster high-impact trials with embedded clinical processes and systems technology and improved data management, greater access to clinical trial matching , and greater benefit to patients, providers, and researchers. Our goal is to improve and save lives. Quantum Leap provides operational, financial, and regulatory oversight to I-SPY. For more information, visit https://www.quantumleaphealth.org …

IBM Watson clinical trial matching program: Mayo Clinic Radio Health Minute | 3/13/2020

IBM Watson clinical trial matching program: Mayo Clinic Radio Health Minute March 13, 2020 In this Mayo Clinic Radio Health Minute, Dr. Tufia Haddad, a Mayo Clinic oncologist explains how Mayo Clinic’s collaboration with IBM Watson , is matching patients with clinical trials. To listen, click the link below …

Confronting the Criticisms Facing Watson for Oncology - The ASCO Post | 3/10/2020

… IBM has launched several other oncology-related offerings aimed at accelerating personalized patient care. They include Watson for Genomics, Watson Genomics from Quest Diagnostics (a Watson-powered genomic-sequencing service), and IBM Watson for Clinical Trial Matching , which uses natural language processing to increase the efficiency and accuracy of the clinical trial matching process. Nathan Levitan, MD, MBA According to Nathan Levitan, MD, MBA , Chief Medical Officer at IBM Watson …

Quantum Leap Healthcare Collaborative Announces the Selection of Regeneron’s Libtayo® (cemiplimab) and REGN3767 for Injection in the I-SPY 2 TRIAL for Breast Cancer | PR Newswire | 12/18/2019

… University of California, San Francisco and Silicon Valley entrepreneurs. Our mission is to integrate high-impact research with clinical processes and systems technology, resulting in improved data management and information systems, greater access to clinical trial matching and sponsorship, and greater benefit to providers, patients, and researchers. Quantum Leap provides operational, financial, and regulatory oversight to I-SPY. For more information, visit www.quantumleaphealth.org . SOURCE Quantum Leap Healthcare Collaborative; I-SPY …

Belong.Life Cancer Clinical Trial Matching Feature Surpasses 6,000 Suggested Patient Matches | PR Newswire | 12/10/2019

NEW YORK , Dec. 10, Belong.Life, creator of the “ Belong- Beating Cancer Together” mobile app, the world’s largest interactive social network for cancer patients, caregivers and healthcare professionals, announced today that it has suggested more than 6,000 clinical trial matches to cancer patients using the Belong app. Clinical trials play a major role in cancer research while also providing patients with access to the latest treatment technologies. However, finding a relevant …

Peter MacCallum Cancer Centre completes IBM Watson trial for lung cancer patients | ZDNet | 12/2/2019

… and found it helped reduce the time it takes for clinicians to match lung cancer patients to relevant clinical trials. According to IBM, using past records of 102 lung cancer patients, IBM Watson for Clinical Trial Matching was able to match each patient to 10 potential trials, achieving a 92% accuracy when compared to manual clinician matching that would typically take “hours”. Peter MacCallum Cancer Centre oncologist and co-chief …

Metastatic Breast Cancer Alliance Announces Release of MBC Connect 2.0 | PR Newswire | 12/2/2019

… to their unique characteristics while researchers can utilize novel tools to glean insights from real world patient data.” MBCA is partnering with BreastCancerTrials.org (BCT) and Quantum Leap Healthcare Collaborative, its parent organization, to enable clinical trial matching on MBC Connect. BCT sources its clinical trial data from ClinicalTrials.gov, the US government’s official registry of clinical trials. To create accurate and patient-friendly results, BCT updates its data from ClinicalTrials.gov on …

Belong.Life Expands to South Africa, Broadens Global Impact | PR Newswire | 11/20/2019

… develop breast cancer in their lifetime. Belong.Life’s free mobile app, Belong – Beating Cancer Together , currently used by more than 200,000 cancer patients and caregivers around the world, provides customized information about treatment and recovery, clinical trial matching , emotional support forums, as well as direct access to medical experts, providers, support programs and more. “The Breast Health Foundation and Pink Parasol project are delighted to collaborate with Belong.Life. This partnership will …

Mayo Clinic’s clinical trial matching project sees higher enrollment in breast cancer trials through use of IBM Watson for Clinical Trial Matching | 10/9/2019

Mayo Clinic started working with IBM Watson for Clinical Trial Matching in 2014. Over time, a team of Mayo experts determined optimal workflows and enhanced patient awareness about clinical trials. The system was implemented with a team of clinical research coordinators in the ambulatory practice for breast cancer. Read this article to learn how Watson for Clinical Trial Matching has enabled Mayo to improve both enrollment metrics for breast cancer …

Mayo Clinic in the News Weekly Highlights for September 27, 2019 | 9/27/2019

… Today , ‘Money Honey’ Maria Bartiromo on Trump, AI and the future of work by Swapna Venugopal Ramaswamy — …Last year, Mayo Clinic and IBM Watson Health unveiled results from early use of the Watson for clinical trial matching for breast cancer. “AI is truly changing our lives,” Bartiromo said. “People think that things that are happening are little incremental gains like Siri or your Echo at home or GPS, but it’s …

Massive Bio Launches A Hub to Assemble The Largest Artificial Intelligence Enabled Just-In-Time Precision Oncology Clinical Trial Network in The World | Business & Finance | manchestertimes.com | Business Wire | 7/30/2019

NEW YORK–(BUSINESS WIRE)–Jul 30, 2019– Massive Bio, Inc. , a leader in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial matching , announces today its newly developed “Hub” aimed to build strategic partnerships with some of the most prominent Just-In-Time (JIT) vendors and provider clinical research teams, looking to facilitate the largest JIT oncology clinical trial network in the world. These vendors and Massive Bio …

Artificial Intelligence Could Increase Clinical Trial Success Rates | HealthIT Analytics | 7/18/2019

… ML, can be used to automatically analyze EHR and clinical trial eligibility databases, find matches between specific patients and recruiting trials, and recommend these matches to doctors and patients,” researchers said. “Such AI-based clinical trial matching systems have successfully been demonstrated and have proved their value in real-life use cases.” AI tools can also help sponsors monitor patient behavior and response to drugs throughout clinical trials, thus helping …

Improved website for My Cancer Genome launched | PR Newswire | 7/9/2019

… cancer medicine and connect with clinical research trials. About GenomOncology GenomOncology has the leading precision oncology platform powered by its proprietary Knowledge Management System (KMS) which enables clinical decision support, virtual molecular tumor boards, clinical trial matching , and advanced analytics. The solutions power clinical decision-making at innovative cancer centers and laboratories worldwide. More information can be found on the company’s website at www.genomoncology.com . 1 The AACR Project GENIE Consortium …

Belong.Life’s $14M Series B will help expand its patient social network, engagement platforms | MobiHealthNews | 7/1/2019

… support others undergoing treatment for dozens of different cancers. But along with providing a social network, the service includes a handful of management tools, such as a document manager, reminder notifications, access to a clinical trial matching service and in-app chats with professionals able to answer common treatment questions. The company also has another platform that incorporates machine learning and artificial intelligence to drive patient engagement for provider, payer …

UK’s NHS Moves to Fast-Track mHealth App Validation Process | mHealth Intelligence | 6/14/2019

… lacking a privacy policy and one even transmitting personally identifying data the policy claimed would be anonymous.” The authors of that study, Paul Wicks and Emil Chiauzzi – employees of PatientsLikeMe, which had a free clinical trial matching tool listed in the NHS Health Apps Library – noted mHealth apps can be and are being reviewed by journals, organizations or commercial sites like iMedicalApps, but the best bet may lie in a …

Multiple myeloma foundation debuts CureCloud to advance precision medicine | Healthcare IT News | 6/13/2019

… the Biden Cancer Initiative’s Oncology Clinical Trial Information Commons – a shared platform where information about clinical trials can be stored and accessed for patient matching and other data mining – partnered with precision medicine and clinical trial matching specialist Massive Bio with the aim of improving access and reducing redundancies in the platform. Currently, many patients are unable to find the clinical trial options that would be relevant for them, and …

Precision medicine player joins Biden Cancer Initiative aiming to improve clinical trials access | Healthcare IT News | 6/7/2019

11:35 AM Share Precision medicine and clinical trial matching specialist Massive Bio is partnering with the initiative. Massive Bio’s precision medicine approach is based on a genetic understanding of the patient, allowing doctors to better select treatments. The Biden Cancer Initiative’s Oncology Clinical Trial Information Commons (OCTIC) is a shared platform where information about clinical trials can be stored and accessed for patient matching and other data mining. The system …

Massive Bio Partners with Biden Cancer Initiative to Improve Access to Oncology Clinical Trials | Business Wire | 6/3/2019

NEW YORK- Massive Bio, Inc., a leader in precision medicine and patient centric clinical trial matching , announces today its partnership in the Biden Cancer Initiative’s Oncology Clinical Trial Information Commons (OCTIC). OCTIC is a shared platform where all information about clinical trials can be stored and accessed for patient matching and other data mining. The system will employ a single set of terms and rules, plus a user-friendly interface …

Belong.Life Launches End-to-end Patient Engagement Platform for Payers, Providers, Pharma and Advocacy Groups | PR Newswire | 5/29/2019

… processes.” The ‘Belong - Beating Cancer Together’ mobile app serves a community of around 200,000 cancer patients and their caregivers, providing key information about recovery, emotional support forums, access to experts who provide educational information, clinical trial matching and more. The ML and AI components of the app have also been used to support international research projects recognized by market leaders and the wider oncology community, including events organized by the …

American Society of Clinical Oncology

Belong.Life Expands to South Africa, Broadens Global Impact | PR Newswire | 11/20/2019

… currently used by more than 200,000 cancer patients and caregivers around the world, provides customized information about treatment and recovery, clinical trial matching, emotional support forums, as well as direct access to medical experts, providers … research projects recognized by the global oncology community, including the American Society of Clinical Oncology (ASCO) and the European Society of Medical Oncology (ESMO). “While breast cancer is common all around the world, gaps in …

Precision medicine player joins Biden Cancer Initiative aiming to improve clinical trials access | Healthcare IT News | 6/7/2019

11:35 AM Share Precision medicine and clinical trial matching specialist Massive Bio is partnering with the initiative. Massive Bio’s precision medicine approach is based on a genetic understanding of the patient, allowing doctors to better … release of OCTIC tools before the 2020 meeting of the American Society of Clinical Oncology. In April, Massive Bio announced it was partnering with Admera Health as an active participant in Synergy-AI registry, focusing …

Patient Engagement Platform

Belong.Life Expands to South Africa, Broadens Global Impact | PR Newswire | 11/20/2019

… currently used by more than 200,000 cancer patients and caregivers around the world, provides customized information about treatment and recovery, clinical trial matching, emotional support forums, as well as direct access to medical experts, providers … cancer patients and their families.” Belong.Life recently launched its new Patient Engagement Platform (PEP) , extending services to a wider range of therapeutic areas and providing end-to-end patient engagement solutions for global payers, pharma …

Belong.Life’s $14M Series B will help expand its patient social network, engagement platforms | MobiHealthNews | 7/1/2019

… social network, the service includes a handful of management tools, such as a document manager, reminder notifications, access to a clinical trial matching service and in-app chats with professionals able to answer common treatment … will be used to expand its social network app and patient engagement platform. THE LARGER TREND Recent discussions on patient social networks have been dominated by the acquisition of PatientsLikeMe by UnitedHealth Group , as well …

Precision Medicine

Massive Bio Launches A Hub to Assemble The Largest Artificial Intelligence Enabled Just-In-Time Precision Oncology Clinical Trial Network in The World | Business & Finance | manchestertimes.com | Business Wire | 7/30/2019

NEW YORK–(BUSINESS WIRE)–Jul 30, 2019– Massive Bio, Inc. , a leader in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial matching, announces today its newly developed “Hub” aimed to build strategic partnerships with some of the most prominent Just-In-Time (JIT) vendors and provider clinical research teams, looking to facilitate the largest JIT oncology clinical trial network in the world. These vendors and Massive Bio …

Multiple myeloma foundation debuts CureCloud to advance precision medicine | Healthcare IT News | 6/13/2019

… has launched the MMRF CureCloud, a centralized data hub that generates, aggregates and visualizes data to accelerate the delivery of precision medicine to multiple myeloma patients. The CureCloud is a critical part of the organization’s … matching and other data mining – partnered with precision medicine and clinical trial matching specialist Massive Bio with the aim of improving access and reducing redundancies in the platform. Currently, many patients are unable to find …

Clinical Decision Support

Improved website for My Cancer Genome launched | Markets Insider | Business Insider | 7/9/2019

… clinical decision support, virtual molecular tumor boards, clinical trial matching, and advanced analytics. The solutions power clinical decision-making at innovative cancer centers and laboratories worldwide. More information can be found on the company’s website at www.genomoncology.com. 1 The AACR Project GENIE Consortium. AACR Project GENIE: Powering Precision Medicine Through An International Consortium, Cancer Discov. 2017 Aug;7(8):818-831. Dataset Version 5. For more information about GenomOncology: Teresa Fletcher …

Improved website for My Cancer Genome launched | PR Newswire | 7/9/2019

… clinical decision support, virtual molecular tumor boards, clinical trial matching, and advanced analytics. The solutions power clinical decision-making at innovative cancer centers and laboratories worldwide. More information can be found on the company’s website at www.genomoncology.com . 1 The AACR Project GENIE Consortium. AACR Project GENIE: Powering Precision Medicine Through An International Consortium, Cancer Discov. 2017 Aug;7(8):818-831. Dataset Version 5. For more information about GenomOncology: Teresa Fletcher …

Digital Health

UK’s NHS Moves to Fast-Track mHealth App Validation Process | mHealth Intelligence | 6/14/2019

… Software News UK’s NHS Moves to Fast-Track mHealth App Validation Process The UK’s National Health Service is launching a digital health portal to enable its experts to review and validate mHealth apps as they’re … and Emil Chiauzzi – employees of PatientsLikeMe, which had a free clinical trial matching tool listed in the NHS Health Apps Library – noted mHealth apps can be and are being reviewed by journals, organizations or commercial …

Philips spotlights AI-powered health information management solutions at HIMSS & Health 2.0 Europe | Globe Newswire | 6/11/2019

… collaborative diagnostic treatment and follow-up decisions by Multidisciplinary Tumor Boards via Dana-Farber Oncology Pathways, Genomic Bioinformatics and Interpretation, Clinical Trial Matching and Clinical Dashboards. Philips Illumeo with Adaptive Intelligence introduces a new paradigm … Index (FHI) report: ‘Transforming healthcare experiences: Exploring the impact of digital health technology on healthcare professionals and patients.’ Now in its fourth year, the report focuses on the role digital health technology plays in improving …

IBM Watson

IBM Watson clinical trial matching program: Mayo Clinic Radio Health Minute | 3/13/2020

IBM Watson clinical trial matching program: Mayo Clinic Radio Health Minute March 13, 2020 In this Mayo Clinic Radio Health Minute, Dr. Tufia Haddad, a Mayo Clinic oncologist explains how Mayo Clinic’s collaboration with IBM Watson , is matching patients with clinical trials. To listen, click the link below …

Peter MacCallum Cancer Centre completes IBM Watson trial for lung cancer patients | ZDNet | 12/2/2019

The Melbourne-based centre used artificial intelligence to match lung cancer patients to relevant clinical trials. Topic: Innovation Getty Images/iStockphoto Melbourne-based Peter MacCallum Cancer Centre has trialled the use of IBM Watson and found it helped reduce the time it takes for clinicians to match lung cancer patients to relevant clinical trials. According to IBM, using past records of 102 lung cancer patients, IBM Watson for Clinical Trial …

IBM Watson Health

‘Money Honey’ Maria Bartiromo on Trump, AI and the future of work | Yahoo News | 9/22/2019

IBM Watson Health unveiled results from early use of the Watson for clinical trial matching for breast cancer. “AI is truly changing our lives,” Bartiromo said. “People think that things that are happening are little incremental gains like Siri or your Echo at home or GPS, but it’s only scratching the surface.” Along with Rometty, Bartiromo interviewed Ford CEO James Hackett, Blackstone CEO Steve Schwarzman and billionaire tech investor Peter …

Massive Bio Partners with Biden Cancer Initiative to Improve Access to Oncology Clinical Trials | Business Wire | 6/3/2019

NEW YORK- Massive Bio, Inc., a leader in precision medicine and patient centric clinical trial matching, announces today its partnership in the Biden Cancer Initiative’s Oncology Clinical Trial Information Commons (OCTIC). OCTIC is a shared … BreastCancerTrials.org, Cancer Commons, Ciitizen, EmergingMed, GenomOncology, Sarah Cannon Research Institute, IBM Watson Health, and Syapse. The announcement was made at the Annual meeting of American Society of Clinical Oncology (ASCO) in Chicago on June 1 …

Mayo Clinic

IBM Watson clinical trial matching program: Mayo Clinic Radio Health Minute | 3/13/2020

IBM Watson clinical trial matching program: Mayo Clinic Radio Health Minute March 13, 2020 In this Mayo Clinic Radio Health Minute, Dr. Tufia Haddad, a Mayo Clinic oncologist explains how Mayo Clinic’s collaboration with IBM Watson , is matching patients with clinical trials. To listen, click the link below …

Mayo Clinic’s clinical trial matching project sees higher enrollment in breast cancer trials through use of IBM Watson for Clinical Trial Matching | 10/9/2019

Mayo Clinic started working with IBM Watson for Clinical Trial Matching in 2014. Over time, a team of Mayo experts determined optimal workflows and enhanced patient awareness about clinical trials. The system was implemented with a team of clinical research coordinators in the ambulatory practice for breast cancer. Read this article to learn how Watson for Clinical Trial Matching has enabled Mayo to improve both enrollment metrics for breast cancer …

Eliran Malki

Belong.Life Cancer Clinical Trial Matching Feature Surpasses 6,000 Suggested Patient Matches | PR Newswire | 12/10/2019

… and anonymous service are matched within 48 hours, on average. “One of the reasons we were inspired to found Belong was the difficulty in finding relevant clinical trials for our family members,” said Eliran Malki , Co-Founder and CEO of Belong. “There is a lot of great research taking place around the world that patients can benefit from, but amidst the difficult cancer treatment, it’s easy to miss trials, even …

Belong.Life Expands to South Africa, Broadens Global Impact | PR Newswire | 11/20/2019

… currently used by more than 200,000 cancer patients and caregivers around the world, provides customized information about treatment and recovery, clinical trial matching, emotional support forums, as well as direct access to medical experts, providers … lack of support and access to medical professionals persist,” said Eliran Malki , co-founder and CEO of Belong.Life. “We are thrilled to expand our footprint to South Africa with our distinguished partners, BHF and The …

Selin Kurnaz

Massive Bio Launches A Hub to Assemble The Largest Artificial Intelligence Enabled Just-In-Time Precision Oncology Clinical Trial Network in The World | Business & Finance | manchestertimes.com | Business Wire | 7/30/2019

… BUSINESS WIRE)–Jul 30, 2019– Massive Bio, Inc. , a leader in precision medicine and artificial intelligence (AI) enabled patient centric clinical trial matching, announces today its newly developed “Hub” aimed to build strategic partnerships with … research services to perform the highest patient enrollment potential”, said Selin Kurnaz, PhD., Co-founder and CEO of Massive Bio. She also added, “We are predominantly looking for strategic partnerships and assessing key targets for …

Massive Bio Partners with Biden Cancer Initiative to Improve Access to Oncology Clinical Trials | Business Wire | 6/3/2019

NEW YORK- Massive Bio, Inc., a leader in precision medicine and patient centric clinical trial matching, announces today its partnership in the Biden Cancer Initiative’s Oncology Clinical Trial Information Commons (OCTIC). OCTIC is a shared … to have access to and knowledge of clinical trials,” said Selin Kurnaz, PhD., Co-founder and CEO of Massive Bio. In addition, she has added that, “Massive Bio is excited to work with the Biden …

Sarah Cannon

Precision medicine player joins Biden Cancer Initiative aiming to improve clinical trials access | Healthcare IT News | 6/7/2019

11:35 AM Share Precision medicine and clinical trial matching specialist Massive Bio is partnering with the initiative. Massive Bio’s precision medicine approach is based on a genetic understanding of the patient, allowing doctors to better … of the OCTIC platform are Cancer Commons, Ciitizen, EmergingMed, GenomOncology, Sarah Cannon Research Institute, IBM Watson Health and Syapse. The members have agreed to work to create a first release of OCTIC tools before the …

Massive Bio Partners with Biden Cancer Initiative to Improve Access to Oncology Clinical Trials | Business Wire | 6/3/2019

NEW YORK- Massive Bio, Inc., a leader in precision medicine and patient centric clinical trial matching, announces today its partnership in the Biden Cancer Initiative’s Oncology Clinical Trial Information Commons (OCTIC). OCTIC is a shared … members are Massive Bio, BreastCancerTrials.org, Cancer Commons, Ciitizen, EmergingMed, GenomOncology, Sarah Cannon Research Institute, IBM Watson Health, and Syapse. The announcement was made at the Annual meeting of American Society of Clinical Oncology (ASCO) in …